Live Breaking News & Updates on Marin Pharmaceutical Inc

Stay updated with breaking news from Marin pharmaceutical inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Sells $1,632,400.00 in Stock

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) Director Jean Jacques Bienaime sold 20,000 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $81.62, for a total transaction of $1,632,400.00. Following the transaction, the director now owns 474,994 shares in the company, valued […] ....

Jean Jacques Bienaime , Robertw Baird , Piper Sandler , Biomarin Pharmaceutical Inc , Avoro Capital Advisors , Capital Research Global Investors , Canaccord Genuity Group , Ameriprise Financial Inc , Morgan Stanley , Vanguard Group Inc , Biomarin Pharmaceutical Company Profile , Barclays Plc , Biomarin Pharmaceutical , Get Free Report , Director Jean Jacques Bienaime , Jacques Bienaime , Marin Pharmaceutical , Research Global Investors , Capital Advisors , Genuity Group , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,

Insider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Sells $157,268.50 in Stock

Insider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Sells $157,268.50 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

George Eric Davis , Piper Sandler , Securities Exchange Commission , Stratos Wealth Partners , Canaccord Genuity Group , Biomarin Pharmaceutical Inc , Mackenzie Financial Corp , Xponance Inc , Wells Fargo Company , Commonwealth Equity Services , Morgan Stanley , Biomarin Pharmaceutical , Get Free Report , Eric Davis , Exchange Commission , Marin Pharmaceutical , Genuity Group , Wells Fargo , Equity Services , Wealth Partners , Financial Corp , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,

National Bank of Canada FI Cuts Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

National Bank of Canada FI Cuts Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Jeffrey Robert Ajer , Jean Jacques Bienaime , Robertw Baird , Hsbc Holdings , Wells Fargo Company , Morgan Stanley , Barclays Plc , Toronto Dominion Bank , National Bank , Royal Bank , Jennison Associates , Biomarin Pharmaceutical Inc , Holdings Channel , Biomarin Pharmaceutical , Free Report , Dominion Bank , Director Jean Jacques Bienaime , Robert Ajer , Marin Pharmaceutical , Get Free Report , Marin Pharmaceutical Inc , Visit Holdingschannel , Biomarin Pharmaceutical Daily ,

Motley Fool Wealth Management LLC Reduces Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Motley Fool Wealth Management LLC trimmed its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 3.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 470,289 shares of the biotechnology company’s stock after selling 18,667 shares during the period. BioMarin Pharmaceutical makes up about 2.4% of Motley Fool Wealth […] ....

Erin Burkhart , Jean Jacques Bienaime , Piper Sandler , Securities Exchange Commission , Kb Financial Partners , Lindbrook Capital , Morgan Stanley , Holdings Channel , Canaccord Genuity Group , Wells Fargo Company , Motley Fool Wealth Management , Castleview Partners , Biomarin Pharmaceutical Inc , Biomarin Pharmaceutical , Free Report , Marin Pharmaceutical , Fool Wealth Management , Marin Pharmaceutical Stock Down , Get Free Report , Wells Fargo , Genuity Group , Exchange Commission , Director Jean Jacques Bienaime , Marin Pharmaceutical Inc , Visit Holdingschannel , Biomarin Pharmaceutical Daily ,

Motley Fool Wealth Management LLC Sells 18,667 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Motley Fool Wealth Management LLC reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 3.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 470,289 shares of the biotechnology company’s stock after selling 18,667 shares during the quarter. […] ....

United States , Jeffrey Robert Ajer , Jean Jacques Bienaime , Robertw Baird , International Assets Investment Management , Royal Bank , Wells Fargo Company , Biomarin Pharmaceutical Inc , Motley Fool Wealth Management , Exchange Commission , Securities Exchange Commission , Canaccord Genuity Group , Asset Management North America Corp , Allspring Global Investments Holdings , Biomarin Pharmaceutical , Free Report , Marin Pharmaceutical , Fool Wealth Management , Global Investments Holdings , Management North America , Assets Investment Management , Nordea Investment Management , Investment Management , Get Free Report , Genuity Group , Wells Fargo ,